Journal
BLOOD
Volume 114, Issue 3, Pages 638-646Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-12-196568
Keywords
-
Categories
Funding
- Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan
- Ministero dell'Universita e della Ricerca Scientifica
- Progetto PRIN (Programmi di ricerca di Rilevante Interesse Nazionale), Rome
- Ministero della Salute
- Progetto Oncologia, Rome
- Compagnia di San Paolo, Turin
- Italian Association against Leukemia
- Mediterranean Institute of Hematology
Ask authors/readers for more resources
In chronic lymphocytic leukemia (CLL), spontaneous regressions are an exceptional phenomenon, whose biologic features are unknown. We describe 9 CLL patients who underwent a spontaneous clinical regression over an 11-year follow-up, despite a residual neoplastic clone detected by flow cytometry. CD38 and ZAP-70 were negative in all cases. Immunoglobulin heavy chain variable region (IgVH) genes, mutated in all 7 evaluable patients, were restricted to the VH3 family in 6, with the usage of V(H)3-30 gene in 2. The light chain variable region genes were mutated in 6 of 8 cases, with the use of V(k)4-1 gene in 3. Microarray analysis of CLL cells showed a distinctive genomic profile with an overrepresentation of BCR-related and ribosomal genes, regulators of signal transduction and transcription. The number of activated T lymphocytes expressing IFN-gamma, TNF-alpha, and IL-4 was similar between CLL in spontaneous regression and healthy persons. In conclusion, spontaneous clinical regressions can occur in CLL despite the persistence of the neoplastic clone, and the biologic features include negative CD38 and ZAP-70, mutated VH3-30 and V(k)4-1 genes. The peculiar gene profile suggests that BCR signaling may play an important role in this scenario as the most significant feature of the leukemic clone in regression. (Blood. 2009; 114: 638-646)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available